Immediate Impact
16 standout
Citing Papers
Long-term safety, tolerability, and efficacy of efgartigimod (ADAPT+): interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis
2024 Standout
Myasthenia gravis: the changing treatment landscape in the era of molecular therapies
2024 Standout
Works of Marie Cleary being referenced
A retrospective study of acetylcholine receptor antibody positive ocular myasthenia in the West of Scotland
2017
The Pattern of Extra-Ocular Muscle Involvement in Ocular Myasthenia
2008
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Marie Cleary | 232 | 303 | 254 | 18 | 456 | |
| David Kirschen | 112 | 177 | 196 | 32 | 426 | |
| Christie L. Morse | 289 | 342 | 183 | 13 | 470 | |
| Wendy Adams | 240 | 221 | 151 | 23 | 483 | |
| H.J. Simonsz | 205 | 244 | 146 | 31 | 462 | |
| David R. Neima | 221 | 162 | 156 | 14 | 433 | |
| Katherine K. Weise | 226 | 354 | 132 | 31 | 458 | |
| Howard M. Eggers | 210 | 181 | 177 | 19 | 465 | |
| T. C. A. Jenkins | 205 | 260 | 308 | 29 | 501 | |
| Raiju J. Babu | 158 | 249 | 316 | 17 | 467 | |
| Nobuyuki Shoji | 296 | 224 | 121 | 48 | 459 |
All Works
Loading papers...